Therapy-enhancing glucan
First Claim
1. A delivery composition comprising an isolated DNA, RNA or plasmid and an effective amount of a barley β
- -glucan for delivery of said DNA, RNA or plasmid into cells, wherein said β
-glucan is not encapsulated, and has an average molecular weight of about 15 to about 350 kD.
1 Assignment
0 Petitions
Accused Products
Abstract
A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal, and at least one antibody for the cancer. A method of treating cancer in a mammal is also disclosed. The method comprises administering a suitable orally administered glucan and at least one antibody for the treatment of cancer to the mammal. In addition a composition for delivery of peptide, protein, RNA, DNA or plasmid comprising effective amount of a beta-glucan is disclosed.
67 Citations
12 Claims
-
1. A delivery composition comprising an isolated DNA, RNA or plasmid and an effective amount of a barley β
- -glucan for delivery of said DNA, RNA or plasmid into cells, wherein said β
-glucan is not encapsulated, and has an average molecular weight of about 15 to about 350 kD. - View Dependent Claims (2, 3, 4, 5, 6)
- -glucan for delivery of said DNA, RNA or plasmid into cells, wherein said β
-
7. A composition for delivering a DNA, RNA or plasmid into a cell consisting essentially of said DNA, RNA or plasmid, and an effective amount of a barley β
- -glucan, wherein said β
-glucan has an average molecular weight of about 15 to about 350 kD. - View Dependent Claims (8, 9, 10, 11, 12)
- -glucan, wherein said β
Specification